General
Abbott receives CE Mark for newest generation of drug-eluting XIENCE coronary stent system
 

Abbott receives CE Mark for newest generation of drug-eluting XIENCE coronary stent system

Shared by:

 
Abbott today announced it received CE Mark for XIENCE Sierra, the newest generation of the company’s gold-standard XIENCE everolimus-eluting coronary stent system.
 
www.news-medical.net
 
1 Nov 2017 - General